Overview

Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants

Status:
Completed
Trial end date:
2020-10-30
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn about how itraconazole and rifampin affect LOXO-305 in healthy participants. Participation could last about 8 weeks.
Phase:
Phase 1
Details
Lead Sponsor:
Loxo Oncology, Inc.
Treatments:
Itraconazole
Rifampin